Patricia Carr - 31 Dec 2021 Form 5 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
SVP, Chief Accounting Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr
Issuer symbol
JAZZ
Transactions as of
31 Dec 2021
Net transactions value
-$33,208
Form type
5
Filing time
14 Jan 2022, 16:19:47 UTC
Previous filing
10 Aug 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale $20,083 -147 -2.4% $136.62 5,888 03 Sep 2021 Direct F1
transaction JAZZ Ordinary Shares Sale $19,517 -143 -2.4% $136.48 5,745 03 Sep 2021 Direct
transaction JAZZ Ordinary Shares Other $6,392 +63 +1.1% $101.46 5,808 30 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 147 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021. This acquisition is exempt pursuant to Rule 16b-3(c).
F2 Shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2021. This transaction is exempt pursuant to Rule 16b-3(c).